Patent details

EP2793886 Title: AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM

Basic Information

Publication number:
EP2793886
PCT Application Number:
PCT/EP/2012/074690
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP128063823
PCT Publication Number:
WO/2013/092237
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM
French Title of Invention:
COMPOSITION PHARMACEUTIQUE INHALABLE COMPRENANT DU TIOTROPIUM
German Title of Invention:
INHALIERBARES MEDIKAMENT ENTHALTEND TIOTROPIUM
SPC Number:

Dates

Filing date:
06/12/2012
Grant date:
24/08/2016
EP Publication Date:
24/08/2016
PCT Publication Date:
27/06/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/10/2014
EP B1 Publication Date:
24/08/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/12/2016
Expiration date:
06/12/2032
Renunciation date:
Revocation date:
02/08/2021
Annulment date:

Owner

From:
07/10/2016
 
 

Name:
Teva Branded Pharmaceutical Products R & D Inc.
Address:
41 Moores Road, Frazer, Pennsylvania 19355, United States (US)

Inventor

Name:
ZENG Xian-Ming
Address:
United States (US)

Priority

1

Priority Number:
201161577315
Priority Date:
19/12/2011
Priority Country:
United States (US)

2

Priority Number:
201200525
Priority Date:
13/01/2012
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/46;

Publication

European Patent Bulletin

1

Issue number:
201727
Publication date:
05/07/2017
Description:
Opposition procedure started

2

Issue number:
202142
Publication date:
20/10/2021
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages